Citi analyst Yigal Nochomovitz lowered the price target on LENZ Therapeutics Inc (NASDAQ: LENZ) to $32.00 (from $34.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Form 424B3 LENZ Therapeutics, Inc. August 14, 2024 4:27 PM LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 40cAugust 14, 2024 4:17 PM Form 10-Q LENZ Therapeutics, Inc. For: Jun 30August 14, 2024 4:16 PM Form 8-K LENZ Therapeutics, Inc. For: Aug 14August 14, 2024 4:09 PM